Artwork

Vital Health Podcast에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Vital Health Podcast 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Player FM -팟 캐스트 앱
Player FM 앱으로 오프라인으로 전환하세요!

Christian Schneider, CMO Biopharma Excellence

49:05
 
공유
 

Manage episode 382687822 series 2401268
Vital Health Podcast에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Vital Health Podcast 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

Christian Schneider is the Chief Medical Officer of Biopharma Excellence, and was formerly the Chief Scientific Officer at the UK’s MHRA. He was the Medical Head for Licensing at the Danish Medicines Agency, and a member of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency.

In this podcast, we discuss the continuing challenges to Europe’s Biopharma competitiveness, and how an improved regulatory environment could be a benefit. Christian also highlights both the risks and opportunities of the EU’s proposed revision of the general pharmaceutical legislation.

This podcast was supported by The European Federation of Pharmaceutical Industries and Associations (EFPIA) and has been recorded in collaboration with PharmaLex GmbH. It is not meant to serve as legal advice and may contain certain marketing statements. PharmaLex and its parent, Cencora, Inc. strongly encourage listeners to review all available information and to rely on their own experience and expertise in making decisions with regard to the information discussed today.

00:00:01 Introduction

00:01:05 What's your day like as a regulator?

00:09:48 Patient access to novel and effective treatments and patient engagement with the EMA.

00:11:40 Availability of data and clinical trials.

00:14:12 Clinical Trials Regulation.

00:15:19 Europe's loss of competitiveness and its role as an innovator.

00:16:36 The importance of Scientific Advice.

00:17:28 Revision of the EU Pharmaceutical legislation: Fostering innovation and streamlining the regulatory process.

00:20:32 Europe losing ground vis-à-vis the USA: Regulatory assessment.

00:27:37 The use of drug-device combinations.

00:32:30 Reimbursement and pricing decisions and criteria for (High) Unmet Medical Needs.

00:41:02 Revising EU Pharmaceutical legislation and creating a future-proof framework for clinical trials and R&D investments.

00:44:15 Ability of Member States to access all medicines.

00:46:27 Recommendations to the European Commission and the EMA on the EU Pharmaceutical package.

See omnystudio.com/listener for privacy information.

  continue reading

101 에피소드

Artwork
icon공유
 
Manage episode 382687822 series 2401268
Vital Health Podcast에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Vital Health Podcast 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

Christian Schneider is the Chief Medical Officer of Biopharma Excellence, and was formerly the Chief Scientific Officer at the UK’s MHRA. He was the Medical Head for Licensing at the Danish Medicines Agency, and a member of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency.

In this podcast, we discuss the continuing challenges to Europe’s Biopharma competitiveness, and how an improved regulatory environment could be a benefit. Christian also highlights both the risks and opportunities of the EU’s proposed revision of the general pharmaceutical legislation.

This podcast was supported by The European Federation of Pharmaceutical Industries and Associations (EFPIA) and has been recorded in collaboration with PharmaLex GmbH. It is not meant to serve as legal advice and may contain certain marketing statements. PharmaLex and its parent, Cencora, Inc. strongly encourage listeners to review all available information and to rely on their own experience and expertise in making decisions with regard to the information discussed today.

00:00:01 Introduction

00:01:05 What's your day like as a regulator?

00:09:48 Patient access to novel and effective treatments and patient engagement with the EMA.

00:11:40 Availability of data and clinical trials.

00:14:12 Clinical Trials Regulation.

00:15:19 Europe's loss of competitiveness and its role as an innovator.

00:16:36 The importance of Scientific Advice.

00:17:28 Revision of the EU Pharmaceutical legislation: Fostering innovation and streamlining the regulatory process.

00:20:32 Europe losing ground vis-à-vis the USA: Regulatory assessment.

00:27:37 The use of drug-device combinations.

00:32:30 Reimbursement and pricing decisions and criteria for (High) Unmet Medical Needs.

00:41:02 Revising EU Pharmaceutical legislation and creating a future-proof framework for clinical trials and R&D investments.

00:44:15 Ability of Member States to access all medicines.

00:46:27 Recommendations to the European Commission and the EMA on the EU Pharmaceutical package.

See omnystudio.com/listener for privacy information.

  continue reading

101 에피소드

Alle episoder

×
 
Loading …

플레이어 FM에 오신것을 환영합니다!

플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.

 

빠른 참조 가이드